Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Antibiotic Development to Advance Patient Treatment Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
Antibiotic Development to Advance Patient Treatment Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Infection Prevention and Control
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
21st Century Cures Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
21st Century Cures Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Infection Prevention and Control
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Infection Prevention and Control
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Infection Prevention and Control
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Infection Prevention and Control, Long-Term Care, Infectious Diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Federal funding for healthcare associated infection prevention programs and antibiotic resistance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Federal funding for healthcare associated infection prevention programs and antibiotic resistance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Federal funding for healthcare associated infection prevention programs and antibiotic resistance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Support funding for Centers for Disease Control and Prevention programs, National Healthcare Safety Network and antibiotic resistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Support funding for Centers for Disease Control and Prevention programs, National Healthcare Safety Network and antibiotic resistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support funding for Centers for Disease Control and Prevention programs, National Healthcare Safety Network and antibiotic resistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support funding for Centers for Disease Control and Prevention programs, National Healthcare Safety Network and antibiotic resistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support funding for Centers for Disease Control and Prevention programs, National Healthcare Safety Network and antibiotic resistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for CDC core programs, Antibiotic Resistance, National Healthcare Safety Network Zika Virus
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Funding for the Centers for Disease Control and Prevention programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for CDC's National Healthcare Safety Network (NHSN), Support for antibiotic resistance initiatives
Filing targets: HOUSE OF REPRESENTATIVES
Support for funding the Centers for Disease Control and Prevention and the National Healthcare Safety Network, Prevention Epicenters, and the Detect and Protect Against Antibiotic Resistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Support for funding the Centers for Disease Control and Prevention and the National Healthcare Safety Network, Prevention Epicenters, and the Detect and Protect Against Antibiotic Resistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for the Centers for Disease Control and Prevention Budget and the National Healthcare Safety Network and Prevention Epicenters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Infection Control Surveyors Worksheet
Filing targets: Centers For Medicare and Medicaid Services (CMS)
Support for NHSN in funding within CDC during Fiscal Year 2013 and injection safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for funding for infection programs within the Centers for Disease Control and Prevention and the Agency for Healthcare Research and Quality. Support for efforts to prevent overuse of antibiotics at the Food and Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Support for infection prevention programs within the Centers for Disease Control and Prevention, prevent antibiotic overuse, and support ongoing funding for the Agency for Healthcare Research and Quality.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Support for NHSN funding at CDC during Fiscal Year 2013 and injection safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for NHSN in funding within CDC during Fiscal Year 2013 and injection safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Injection safety issues and requests for certain line items in FY 2013 budget.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for infection prevention/public health programs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for infection prevention/public health programs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for infection prevention/public health programs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE